University Of Birmingham
Clinical trials sponsored by University Of Birmingham, explained in plain language.
-
New hope for blood cancer patients: major trial tests ruxolitinib against standard care
Disease control Recruiting nowThis study tests whether ruxolitinib works better than current standard treatments (hydroxycarbamide or interferon) for people with high-risk polycythemia vera, a blood cancer that increases red blood cells. About 586 adults with high-risk disease will be randomly assigned to rux…
Phase: PHASE3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 16, 2026 23:36 UTC
-
New hope for lymphoma patients: REFRACT trial seeks better therapies
Disease control Recruiting nowThis study is for people with follicular lymphoma that has come back or not responded to treatment. It compares new experimental therapies to the current standard care to see which works better. About 284 adults will take part, and the main goal is to see if the new treatments ca…
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 16, 2026 23:18 UTC
-
Cannabis drug could extend life in aggressive brain cancer
Disease control Recruiting nowThis study tests whether adding a cannabis-based mouth spray (Nabiximols) to standard chemotherapy can help people with a returning, aggressive brain tumor (glioblastoma) live longer. About 120 adults whose tumor has returned after initial treatment will be randomly assigned to r…
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 16, 2026 23:17 UTC
-
Poop pills could tame rare liver disease
Disease control Recruiting nowThis study tests whether a fecal microbiota transplant (FMT) can improve liver health in people with primary sclerosing cholangitis (PSC) and inflammatory bowel disease. About 58 adults will receive either FMT or a placebo. The main goal is to see if FMT lowers a key liver enzyme…
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 16, 2026 23:17 UTC
-
New hope for blood cancer patients: safer stem cell transplants on the horizon
Disease control Recruiting nowThis study tests three different drug combinations to prevent graft-versus-host disease (GVHD) in 400 people with blood cancers receiving stem cells from unrelated donors. GVHD is a serious complication where donor cells attack the patient's body. The goal is to find which approa…
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Whey protein before meals may tame blood sugar spikes in seniors with diabetes
Disease control Recruiting nowThis study looks at whether drinking whey protein before meals can help older adults (ages 75-90) with type 2 diabetes keep their blood sugar levels steadier throughout the day. Over two 7-day periods, participants will take either a whey protein drink or a placebo before each me…
Phase: NA • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hope for kids with tough lymphoma: global trial launches
Disease control Recruiting nowThis study tests new drugs for children and teens with B-cell non-Hodgkin lymphoma that has come back or not responded to treatment. Current treatments cure only about 30% of these patients and have harsh side effects. The trial will give participants one of several new medicines…
Phase: PHASE2, PHASE3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Which brain procedure best saves sight? new trial aims to find out
Disease control Recruiting nowThis study compares two common procedures—CSF shunting and dural venous sinus stenting—to see which is better at preserving vision in adults with idiopathic intracranial hypertension (IIH) who are at risk of permanent sight loss. About 80 participants will be randomly assigned to…
Phase: NA • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New hope for kids with Tough-to-Treat cancer: BEACON2 trial launches
Disease control Recruiting nowThis study is for children and young adults whose neuroblastoma has come back or not responded to standard treatment. It tests different combinations of drugs to see which works best and is safe. About 160 participants will receive one of three treatment plans, including targeted…
Phase: PHASE1, PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
New group therapy aims to heal birth trauma
Symptom relief Recruiting nowThis study tests a group therapy program (GTEP) for people who have had a traumatic birthing experience. Ten participants will attend online group sessions and report changes in trauma symptoms, wellbeing, and bonding with their baby. The goal is to see if this approach is feasib…
Phase: NA • Sponsor: University of Birmingham • Aim: Symptom relief
Last updated May 16, 2026 23:16 UTC
-
Grape power: could a bowl of grapes shield your brain from stress?
Symptom relief Recruiting nowThis study looks at whether eating grapes rich in natural compounds called flavonoids can protect brain function, blood flow, and mood during mental stress in healthy young adults aged 18-40. Participants will consume either a high-flavonoid grape powder or a low-flavonoid contro…
Phase: NA • Sponsor: University of Birmingham • Aim: Symptom relief
Last updated May 06, 2026 16:03 UTC
-
Brain tumor breakthrough: genetic testing could revolutionize glioma care
Knowledge-focused Recruiting nowThis study aims to improve how brain tumors (gliomas) are diagnosed and treated by using advanced genetic testing. Researchers will analyze tumor samples from 1,000 participants to identify specific genetic changes and match them with targeted therapies. The goal is to provide mo…
Sponsor: University of Birmingham • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC